Immatics Intangible Assets vs Accounts Payable Analysis
| IMTXW Stock | USD 0.30 0.06 16.67% |
Immatics Biotechnologies financial indicator trend analysis is infinitely more than just investigating Immatics Biotechnologies recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immatics Biotechnologies is a good investment. Please check the relationship between Immatics Biotechnologies Intangible Assets and its Accounts Payable accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in immatics biotechnologies GmbH. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Intangible Assets vs Accounts Payable
Intangible Assets vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immatics Biotechnologies Intangible Assets account and Accounts Payable. At this time, the significance of the direction appears to have very week relationship.
The correlation between Immatics Biotechnologies' Intangible Assets and Accounts Payable is 0.24. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of immatics biotechnologies GmbH, assuming nothing else is changed. The correlation between historical values of Immatics Biotechnologies' Intangible Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of immatics biotechnologies GmbH are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Intangible Assets i.e., Immatics Biotechnologies' Intangible Assets and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.24 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Intangible Assets
Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.Accounts Payable
An accounting item on the balance sheet that represents Immatics Biotechnologies obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Immatics Biotechnologies are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from Immatics Biotechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immatics Biotechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in immatics biotechnologies GmbH. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. Sales General And Administrative To Revenue is likely to climb to 1.03 in 2024, whereas Tax Provision is likely to drop 0.00 in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 5.7M | 9.4M | 13.8M | 14.5M | Net Interest Income | 3.9M | 1.1M | 13.0M | 13.7M |
Immatics Biotechnologies fundamental ratios Correlations
Click cells to compare fundamentals
Immatics Biotechnologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immatics Stock Analysis
When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.